Time | Trial arm | Pairwise comparisons | |||||
Group | Individual | UC | Group–UC | Individual–UC | Individual–group | ||
LDL cholesterol (mmol/mol) | Baseline | 3.11 (0.85) | 3.14 (0.89) | 3.07 (0.88) | |||
12 months | 2.93 (0.85) | 2.92 (0.83) | 2.91 (0.87) | 0 (−0.07 to 0.07) | 0 (−0.07 to 0.08) | 0 (−0.07 to 0.08) | |
24 months | 3.04 (0.90) | 3.02 (0.88) | 2.94 (0.90) | 0.07 (−0.01 to 0.15) | 0.05 (−0.04 to 0.14) | −0.02 (−0.10 to 0.07) | |
QRisk2 score (%) | Baseline | 24.95 (4.79) | 25.26 (5.27) | 24.93 (4.81) | |||
12 months | 25.18 (5.60) | 25.54 (5.93) | 25.50 (6.04) | −0.28 (−0.79 to 0.23) | −0.14 (−0.68 to 0.40) | 0.14 (−0.36 to 0.64) | |
24 months | 26.73 (7.12) | 27.04 (6.59) | 26.69 (6.76) | 0.01 (−0.68 to 0.71) | 0.05 (−0.63 to 0.72) | 0.03 (−0.64 to 0.71) |
Cell values are mean (SD) or estimate (95% CI).
LDL, low-density lipoprotein; UC, usual care.